LIPO 8-K 2026-07-15

LIPELLA PHARMACEUTICALS INC. (LIPO) 8-K dated 2026-07-15 — accession 0001753926-26-001173. This URL is the filing, not the LIPO hub.

LIPELLA PHARMACEUTICALS INC. (LIPO) is a biotechnology company listed on NASDAQ.

LIPELLA PHARMACEUTICALS INC. filed a 8-K on 2026-07-15. Accession 0001753926-26-001173.

Cached items: 1.03, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported LIPO revenue for 2024-12-31 was $536.4K. Net income was -$5.0M. Revenue was up 19.3% from 2023-12-31 to 2024-12-31. LIPO currently screens at market cap $254.1K.

Not investment advice. The LIPO SEC hub lists recent forms. The stock page is the research view.